EUVIMEDEUVIMED entdecken
Crossref

Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study

Şenay Burçin Alkan iD, Mehmet Artaç iD, Faruk Aksoy iD, Mehmet Metin Belviranlı iD, Mehmet Gürbilek iD, Hilal Akay Çizmecioğlu iD, Neslişah Rakıcıoğlu iD

Supportive Care in Cancer · 2023

DOI: 10.1007/s00520-023-07772-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2023. Verfasst von Şenay Burçin Alkan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Dietetics, Nezahat Keleşoğlu Faculty of Health Sciences, Necmettin Erbakan University, Konya, Turkey. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study is aimed at evaluating the relationship between dietary and serum advanced glycation end-products (AGEs) with serum inflammatory and oxidative stress biomarkers in breast cancer (BC). METHODS: A sample of BC patients was followed for 12 months (March 2020-January 2022). Three-day food consumption record and serum samples were taken before surgery (T1), before chemotherapy (T2), at the 6th month of chemotherapy (T3), and at the 12th month of chemotherapy (T4). Dietary AGE intake was represented by carboxymethyl lysine (dCML). Serum levels of CML, inflammation, and oxidation biomarkers were determined with biochemical blood tests. The results were compared according to human epidermal growth factor receptor-2 (HER2) status. RESULTS: Thirty-two women with BC and 32 age and body mass index-matched healthy women participated. No significant correlation was found between dCML and serum CML, inflammatory or oxidative stress biomarkers at T1, T2, and T4. A weak positive correlation was demonstrated between dCML and serum malondialdehyde levels (rho=0.355, p=0.046) at T3. The serum CML, inflammation, and oxidation biomarker levels of the HER2- group were significantly higher than those of the HER2+ group at T1. CONCLUSION: This study suggests that there is limited correlation between dCML and serum inflammation and oxidative stress biomarkers in BC patients. Inflammation and oxidative biomarker levels appear to decline with treatment although dietary and serum AGE levels show not a corresponding significant decline. The HER2- subtype appears to be associated with higher dietary and serum AGEs and higher inflammatory and oxidative stress biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycation End Products, AdvancedBreast NeoplasmsHumansFemaleFollow-Up StudiesMaillard ReactionBiomarkersInflammation

Stichwörter der Autor:innen

Advanced glycation end productsBreast cancerInflammationOxidation

Substanzen

Glycation End Products, AdvancedBiomarkers

Autor:innen und Institutionen

  • Department of Nutrition and Dietetics, Nezahat Keleşoğlu Faculty of Health Sciences, Necmettin Erbakan University, Konya, Turkey.
  • Department of Medical Oncology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Department of General Surgery, Trabzon Kanuni Training and Research Hospital, University of Health Sciences, Trabzon, Turkey.
  • Department of General Surgery, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Department of Biochemistry, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey.

ORCID-Profile: Şenay Burçin Alkan, Mehmet Artaç, Faruk Aksoy, Mehmet Metin Belviranlı, Mehmet Gürbilek, Hilal Akay Çizmecioğlu, Neslişah Rakıcıoğlu

Zitieren

APA

Alkan, Ş. B., Artaç, M., Aksoy, F., Belviranlı, M. M., Gürbilek, M., Çizmecioğlu, H. A., & Rakıcıoğlu, N. (2023). Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-023-07772-w

Vancouver

Alkan ŞB, Artaç M, Aksoy F, Belviranlı MM, Gürbilek M, Çizmecioğlu HA, et al. Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study. Supportive Care in Cancer. 2023. doi:10.1007/s00520-023-07772-w

BibTeX
@article{Alkan2023,
  author = {Alkan, Şenay Burçin and Artaç, Mehmet and Aksoy, Faruk and Belviranlı, Mehmet Metin and Gürbilek, Mehmet and Çizmecioğlu, Hilal Akay and Rakıcıoğlu, Neslişah},
  title = {Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study},
  journal = {Supportive Care in Cancer},
  year = {2023},
  doi = {10.1007/s00520-023-07772-w}
}
Kostenlos starten →